WEOS Finger Lakes Public Radio

Brian Mann

Copyright 2021 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

RACHEL MARTIN, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AUDIE CORNISH, HOST:

After more than a year of high-stakes negotiations with billions of dollars on the line, a bankruptcy plan for Purdue Pharma, the maker of OxyContin, cleared a major hurdle late Wednesday.

Federal Judge Robert Drain in White Plains, N.Y., moved the controversial deal forward despite objections from dozens of state attorneys general, setting the stage for a final vote by the company's creditors expected this summer.

The drugmaker filed for Chapter 11 protection in 2019 facing an avalanche of lawsuits tied to its aggressive opioid sales practices.

Updated May 3, 2021 at 9:51 PM ET

A senior Drug Enforcement Administration official told NPR efforts to target drug cartels operating inside Mexico have unraveled because of a breakdown in cooperation between law enforcement agencies and militaries in the two countries.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

MICHEL MARTIN, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

RACHEL MARTIN, HOST:

McKinsey & Company has reached a $573 million settlement with nearly 50 state governments as well as the District of Columbia and territories, over its role helping to market and boost sales of high-risk opioids including OxyContin.

Most of the funds will be devoted to paying for treatment and rehabilitation programs in communities devastated by the addiction crisis. As part of the settlement, McKinsey admits to no wrongdoing.

This deal heads off civil lawsuits threatened by state attorneys general.

Pages